Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis.

Abstract

Expression of PAX2 (Paired-box 2) is suppressed through promoter methylation at the later stages of embryonic development, but eventually reactivated during carcinogenesis. Pax-2 is commonly expressed in the most prevalent renal cell tumour (RCT) subtypes-clear cell RCC (ccRCC), papillary RCC (pRCC) and oncocytoma--but not in chromophobe RCC (chrRCC), which frequently displays chromosome 10 loss (to which PAX2 is mapped). Herein, we assessed the epigenetic and/or genetic alterations affecting PAX2 expression in RCTs and evaluated its potential as biomarker. We tested 120 RCTs (30 of each main subtype) and four normal kidney tissues. Pax-2 expression was assessed by immunohistochemistry and PAX2 mRNA expression levels were determined by quantitative RT-PCR. PAX2 promoter methylation status was assessed by methylation-specific PCR and bisulfite sequencing. Chromosome 10 and PAX2 copy number alterations were determined by FISH. Pax-2 immunoexpression was significantly lower in chrRCC compared to other RCT subtypes. Using a 10% immunoexpression cut-off, Pax-2 immunoreactivity discriminated chrRCC from oncocytoma with 67% sensitivity and 90% specificity. PAX2 mRNA expression was significantly lower in chrRCC, compared to ccRCC, pRCC and oncocytoma, and transcript levels correlated with immunoexpression. Whereas no promoter methylation was found in RCTs or normal kidney, 69% of chrRCC displayed chromosome 10 monosomy, correlating with Pax-2 immunoexpression. We concluded that Pax-2 expression might be used as an ancillary tool to discriminate chrRCC from oncocytomas with overlapping morphological features. The biological rationale lies on the causal relation between Pax-2 expression and chromosome 10 monosomy, but not PAX2 promoter methylation, in chrRCC.

• Authors: Patrícia Patrício, João Ramalho-Carvalho, Pedro Costa-Pinheiro, Mafalda Almeida, João Diogo Barros-Silva, Joana Vieira, Paula Cristina Dias, Francisco Lobo, Jorge Oliveira, Manuel R Teixeira, Rui Henrique, Carmen Jeronimo
• Journal: Journal of cellular and molecular medicine (J Cell Mol Med) Vol. 17 Issue 8 Pg. 1048-58 (Aug 2013) ISSN: 1582-4934 [Electronic] England
• PMID: 23890189 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2013 The Authors. Journal of Cellular and Molecular Medicine Published by Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.

Chemical References

• PAX2 Transcription Factor
• PAX2 protein, human
• RNA, Messenger

Topics

• Adenoma, Oxyphilic (diagnosis, genetics, pathology)
• Adult
• Aged
• Aged, 80 and over
• Base Sequence
• Carcinoma, Renal Cell (diagnosis, genetics, pathology)
• Cell Nucleus (metabolism, pathology)
• Chromosomes, Human, Pair 10 (genetics)
• DNA Methylation (genetics)
• Diagnosis, Differential
• Female
• Gene Dosage (genetics)
• Gene Expression Regulation, Neoplastic
• Humans
• Immunohistochemistry
• In Situ Hybridization, Fluorescence
• Kidney Neoplasms (diagnosis, genetics, pathology)
• Male
• Middle Aged
• Molecular Sequence Data
• PAX2 Transcription Factor (genetics, metabolism)
• Promoter Regions, Genetic (genetics)
• RNA, Messenger (genetics, metabolism)
• Reverse Transcriptase Polymerase Chain Reaction